Ex-Juno execs launch cell therapy start-up Sana

Former Juno Therapeutics Inc. executives Steve Harr and Hans Bishop launched Sana Biotechnology Inc. (Seattle, Wash.) on Friday with the goal of aggregating R&D and manufacturing capabilities across the cell and gene therapy treatment paradigms.